Nicholas Bernhardt-Lanier
I work at the intersection of health and technology.
Building
I was co-founder and CEO of Proto Intelligence, an LLM-native clinical OS automating 80% of care operations. Before that, VP of Product and employee #1 at Humanaut Health, a 50-state longevity clinic powering 700+ biomarkers and regenerative therapeutics. Earlier I was on the early GenAI team at McKinsey, and a PM at Doc.ai.
I'm on the advisory board of the Stanford Center on Longevity, a CERC fellow at Stanford Medicine, and a certified home health aide.
Exploring
A handful of threads I keep pulling on. Notes here are deliberately rough โ closer to a working file than an essay.
- Techno-feudalism. The AI platforms we depend on won't behave like markets, they'll behave like fiefs. Who collects rent (compute), who owes loyalty (data), and what happens when the people fight back.
- Biological inequality. The next generation of therapeutics, peptides, gene therapies, AI-personalized medicine, will reach the wealthy first by an order of magnitude. The question is whether the gap closes in years, or whether we stratify into a permanently tiered biology.
- The psychosomatic effects of chatbots. A generation is about to grow up doing daily emotional work with language models. That will rewrite how people think, feel, and cope, long before we have the studies to explain and solve it.
- Enterprise re-orgs around AI. The largest governance transformation since the assembly line, with no playbook. The orgs that figure out which decisions belong to humans and which to models will compound at an exponential rate.
Reading
A running list of what I've read lives here.
Playing
Tradle โ Wordle but for global exports.
I compete in Hyrox and Olympic triathlons, and experiment on my own health optimization.